Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Intravenous Iron
100%
Ferumoxytol
100%
Facility Level
100%
Incident Hemodialysis Patients
100%
Iron Sucrose
87%
Ferrous Gluconate
87%
Hemodialysis
50%
Hospitalization
25%
Cardiovascular Mortality
25%
Cardiovascular Events
25%
Clinical Application
12%
Confidence Interval
12%
Anemia
12%
Medicare
12%
Adjusted Hazard Ratio
12%
Safety Profile
12%
Patient Outcomes
12%
Peritoneal Dialysis
12%
All-cause Mortality
12%
Kidney Transplantation
12%
End-stage Renal Disease
12%
Cox Proportional Hazards Regression
12%
Cardiovascular Outcomes
12%
Exposure Groups
12%
Mortality Outcomes
12%
Oral Iron
12%
Stroke Mortality
12%
Hemodialysis Units
12%
End-stage Renal Disease Patients
12%
Patient-initiated
12%
Infectious Outcomes
12%
United States Renal Data System (USRDS)
12%
Cardiovascular Hospitalizations
12%
Iron Exposure
12%
Myocardial Infarction Stroke
12%
Infectious Events
12%
Iron Formulations
12%
Nursing and Health Professions
Hemodialysis
100%
Ferumoxytol
100%
Iron Saccharate
87%
Ferric Gluconate
87%
Cardiovascular System
75%
End Stage Renal Disease
25%
Treatment Outcome
12%
Proportional Hazards Model
12%
Confidence Interval
12%
Hazard Ratio
12%
Medicare
12%
Heart Infarction
12%
Anemia
12%
Cerebrovascular Accident
12%
All Cause Mortality
12%
Kidney Transplantation
12%
Peritoneal Dialysis
12%
Efficacy
12%
Accident Prevention
12%
Cardiovascular Infection
12%
Pharmacology, Toxicology and Pharmaceutical Science
Hemodialysis
100%
Ferumoxytol
100%
Iron Saccharate
87%
Ferric Gluconate
87%
End Stage Renal Disease
25%
Anemia
12%
Comparison Trial
12%
All Cause Mortality
12%
Heart Infarction
12%
Cerebrovascular Accident
12%
Cardiovascular Infection
12%